ClinicalTrials.Veeva

Menu

Peri-Operative Lidocane, Ketamine, or Lidocane and Ketamine Combination, Infusion for Patients Undergoing Spine Surgery

Beth Israel Lahey Health logo

Beth Israel Lahey Health

Status and phase

Completed
Phase 3

Conditions

Postoperative Pain

Treatments

Other: Saline
Drug: Lidocaine
Drug: Ketamine

Study type

Interventional

Funder types

Other

Identifiers

NCT01983020
IRB 073-10

Details and patient eligibility

About

This study has been designed as a controlled clinical trial to evaluate the efficacy of brief lidocaine infusion, brief ketamine infusion and a lidocaine/ketamine combined infusion when added to conventional opioid therapy following major spine surgery, as well as to evaluate the effects of the lidocaine/ketamine pain protocol on the feasibility of performing routine intraoperative neurophysiology during spine surgery in adults and determine whether this infusion protocol is compatible with intraoperative neurophysiology on spine surgery patients. If one or more of the approaches is confirmed as efficacious and safe, it could have a significant impact on the routine management of postoperative pain in this context.

Enrollment

46 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Male and Female >/= 18 years of age Patients undergoing first-time fusion surgery or surgery to revise a prior fusion Able to read, write and speak in English, and able to give informed consent for the study

Exclusion criteria

Any disease associated with major organ dysfunction renal dysfunction hepatic dysfunction cardiac dysfunction

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

46 participants in 4 patient groups, including a placebo group

Ketamine
Experimental group
Description:
Ketamine infused at 0.25 mg/kg/hour.
Treatment:
Drug: Ketamine
Lidocaine
Experimental group
Description:
Lidocaine infused at 0.5 mg/kg/hour.
Treatment:
Drug: Lidocaine
Ketamine and Lidocaine
Experimental group
Description:
Ketamine infused at 0.25 mg/kg/hour along with lidocaine at 0.5 mg/kg/hour
Treatment:
Drug: Lidocaine
Drug: Ketamine
Placebo
Placebo Comparator group
Description:
Placebo (saline) given to compare usual treatment against active agents in post operative pain management.
Treatment:
Other: Saline

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems